04:31 PM EDT, 06/03/2025 (MT Newswires) -- Merus (MRUS) said late Tuesday it plans an underwritten public offering of its shares, with book-runners including Jefferies, BofA Securities, Leerink Partners and Guggenheim Securities.

The company said it will offer its underwriters a 30-day option to buy up to an additional 15% of the offer shares.

Merus said it plans to use the proceeds for developing drug candidates, clinical research, and general corporate purposes.

Shares were down over 6% in after-hours trading.